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ABSTRACT 
D i spo s i t i o n  k i net ics o f  i m i d ocarb , an an t i pr o t ozoan d r u g, 
wa s s t ud ied i n  no rmal and f eb r i le d o g s  and goa t s .  Fever was 
i nd uced u s i n g  � col i end o toxin, Trypano s oma evan s i  and Inf ec t i o u s  
Bovine Rh i no t r ache i t is (IBR) v i r u s . The object i ve s  o f  t he s t udy 
were t o  compare t he d i spo s i t i o n  k i ne t ics o f  i m i docarb in ruminant  
and monoga s t r ic s pecies,  and t he i nfluence of  fever of  dif feren t 
e t i ology on t he d i s po s i t i on k i net ics o f  th i s  d r u g . The co ncen t ra-
t i on o f  i m i d o carb in b o d y  flu i d s  and t i s s ues were mea s u red by 
spect roph o t ome t r y . 
The d i spo s i t i o n  k i ne t i c s  o f  i m i d oca r b  i n  no rmal and feb r i le 
d o g s  and goa t s  can b e  adequ a t ely descr ibe� by a t wo-compa r tmen t  
open model. The appar ent volume o f  t he cen t ral compar t men t ,  V , 
c 
was s i gn i f ican t ly lower (P<O.Ol) b u t  t he volume o f  dis t r ib u t i on, 
V wa s s i g n if i ca n t ly h i gher (P<O.05) i n  normal goa t s  t han 
d(area ) 
in dogs . H i gher volume o f  d i s t r ib u t i o n  and t he r a t i o  o f  i m i docarb 
level in per i pheral- t o-cen t r al compartment in  goa t s  ( 6 :1 ) 
prolonged elim i na t i o n  o f  t he d rug, resul t i n g  i n  co n s i derably 
higher levels o f  the drug still presen t  i n  t he tissues 14 days 
a f ter a s i ngle s ubcu t aneo u s  or i ntramuscula r d o se . Thu s  t he 
w i thd rawal t i me o f  imidoca rb was es t ima t ed t o  be 5-6 weeks i n  t h i s 
f oo d-pro d uc i ng s pec i es . D i f ferences i n  t he k i ne t i c  d i s po s i t i o n  
o f  i m i d oca rb i n  d o g s  and g o a t s  may be lar gely a t t r i b uted t o  t he 
ana t omical and phy s i ologi cal d i f ferenc�s in  t he ga s t ro i n tes t i nal 
t ract b e t ween the t wo s pec i es. 
The res ult s of  the presen t  s t udy i nd i ca t e  tha t fever of  
d i ffe ren t e t i olo g i e s  affect ed t he d i spos i t i on k i ne t ics of imidocarb 
11 
differently . Plasma c oncentrations o f  imidoc arb were higher than 
norma l during endotoxin-induced fever but lower during Trypanosoma-
induced fever. Although c oncentrations o f  imid o c arb in the p l asma 
o f  go ats were not a f fected by the IB R viral-induced fever, t he 
apparent volume o f  distribution, V
d ( )' and the steady-state area 
volume of distribution, V
d ( ss)
' were significantly l owered as In 
the endotoxin-induced fever. Simil ar ly, the above kinetic 
parameters as wel l  as �o lume o f  centra l c ompartment, V , and the 
c 
body c learances C1B were signific antly higher ( P<O . Ol ) in d o gs and 
go ats during Trypanosoma-induced fever than in the norma l animals 
a lthough the p lasma c oncentrations were substantia l ly reduced 
during the f ebrile reaction. The micro c onstants were also a f fected 
dif ferentl y  by fever o f  dif ferent etiolo gy. Nevertheless, ha l f-
life o f  imido c arb remained unaf fected during the three febrile 
c onditions. 
Theref ore, it cou l d  be hypothesized that fever o f  dif f erent 
etiology a f fected the disposition kinetic s  o f  imido carb dif ferently 
and the inf luence of f ever on pharmacokinetics should be c onsidered 
beyond the p l asma c oncentrations and h a l f -life o f  the drug itse l f. 
Furthermore, the pathophysiology of the disease and not just the 
febrile state should be considered when eva luating the inf luence 
of disease c onditions on the disposition kinetics o f  a drug . 
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d i s p o s i t i o n  kin e t i c s  o f  i m i d o c arb i n  fe b r i l e  
( e ndo t o xi n - i nd u c e d  feve r )  go at s ( n = 6) fo l l o wi n g  
i nt r ave no u s  i n je ct i o n  o f  a s i ngl e d o se ( 4  mg/ kg) 
o f  12% i m i d o c arb d i p rop i onate  s ol u t i on 
Pharmac oki ne t ic p ar ame t e rs ( m e an ± SD)  
d e s cr ib i ng t he d i s po s i t i o n  kine ti c s  o f  
imido carb i n  t h e  normal ( n=7 ) and feb r i l e  
( endo t o x i n-ind uced fev e r )  d o gs ( n= 6) 
fo l l owing int r ave no u s  i nje ct i o n  o f  a s ingl e 
d o s e  (4 m g/kg) o f  12% i m i d o carb d i p ro p i o nat e 
so lution 
Ph arma c o k i ne t ic p arame t e r s  (mean ± SD) 
d e s c r ib i n g  t he d i s p o s i t i o n  ki ne t i c s  o f  
imid o c arb i n  t h e  no rmal ( n = 8 )  and feb r i l e  
( en d o to x i n- i n d u c e d  f eve r )  goats ( n= 6) 
fo l l ow i n g  i nt r av e no u s  i nj e c t i o n  o f  a s i n gl e 
d o s e  ( 4  mg/ kg) o f  1 2% i mi d o carb d i p rop i o nat e 
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T he me an ± SD o b s e r ve d  (meas u r e d )  pl asma 
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fo ll o wi n g  i nt r aven ou s  inje cti on of a s ingle 
d o s e  ( 4  mg/ kg) o f  12 % i m i d o car b d i prop i o na t e  
s o l ut i o n  
Pha rmacoki n e t i c p ar ame t e r s  d e s cr i b i n g the 
d i s p o s i t i o n  kine t i cs o f  i m i d o carb i n  t h e  
feb r i l e  (Tryp ano s oma- in d u ce d  f e ve r )  d o gs (n =6 ) 
f o llow i n g  i n t r aveno us inje cti o n  o f  a s in gle 
d ose (4 mg/kg) of 12% imidocarb dipropionat e 
s o lut ion 
P harm ac okin e tic p a rame t e rs (me an ± S D )  
d e s cr i b i n g  t h e  di s po s i t i o n  k i n e t i cs o f  i m i d o carb 
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d o gs ( n = 6 )  f o l lowi n g  i n t r aven o us i n je ct i o n  o f  
a s in gle d o s e  ( 4  mg/ kg) o f  1 2 %  i m i d o ca rb 
d i prop ion at e s o lution 
Pharmaco k i n e t i c  pa r ame t e r s  d e s cr ib i ng t h e  
d i s pos it i on kin e t i cs of i m id o carb in the 
feb r i l e ( Tryp ano s oma- in d uce d fe ve r )  go at s 
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d e s c r ib i ng t h e  d i s p o s i t i o n  k i ne t i c s  o f  
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i nje c t i o n  o f  a s ing l e  d o s e  ( 4  m g / k g )  o f  
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Pharmac ok i ne t ic p ar ame t e r s  d e s c r ib i ng 
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Inf e c t i o us d i s ea s e  s y s t em. In the  c o urs e 
o f  an i n f e c t i o us d i s e a s e  and c o n t in uo us 
an ti b i o t i c  t re atme n t  the body  o f  the ho s t  ( H ) , 
the m i c rob e s  (M) and the an t ib ac t e ri al d rug 
( D )  a r e  the  i n t e rd e p endent  vari a b l e s  o f  a 
comp l ex s y s t em . The i n t e ra ct i o n s  i n  the 
s y s t em are: 1: Ph arma c o k i n e ti c s  (H  ---4 D), 
2 :  D rug tox ic it y  ( D  � H ) , 3 :  H o st 's 
d e f en s e  mechani sms (H ---I H), 4 :  B a c t e ri a l  
t o x i c i ty (H ----+ H ) , 5 :  Pharma co d ynam i c s  
( D  � l'1), 6 :  B a ct e ri al d ef e n s e  me c ha n i sms 
eM --l D) • (From H ind e rl ing,  1 97 8. Si gn i -
Page 
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f i c an c e of t h e  p h arma c o ki ne t i cs o f  an t im i c rob i al 
d rugs .  S cand . J .  Inf e c t . D i s . Sup p l .  14:2 5 - 3 5 ) . 
Schemati c d i a gram o f  the two-compa rtment 
op en mo d e l. The d o s e  o f  d rug i s  i n t ro d uc e d  
in t o  t h e  c e nt ral comp a rtme n t ,  whe re i t  
d is t rib ut e s  i n s t an t ane o us l y . D i s trib ut ion 
b e tween cen t ra l  and p e rip h e ral co mpart men t s  
t ake s p l ace mo re s l owl y ;  k
12  
and k21 are  
f i rs t -o rde r ra t e  c on s t an t s  for  d rug t ran s fe r  
b e t ween the  t wo c omp artmen t s . E l i m i n at i o n, 
wh i ch c om p ri s e s  b i o t ran s f o rmat i o n  and  
e x c re t i on , is  a s s umed t o  o cc ur e x c l us i ve l y  
f rom t he c e n t ra l  c ompa rt ment ; k
e l  
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whic h d e s c r ibe s t he dis pos it io n  c u r ve IS 
s hown. ( From B aggo t ,  19 7 7 ) . Pr in c ip l e s  o f  
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fever. Endogenous pyrogen circu l at e s  to the 
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pro d uct io n  of a m etab ol ite of arach idonic acid. 
Thi s sub stance, i n  turn, i nc r e ase s th e 
synth es i s  of n e r e pi�e p h r i ne , an a lp ha-adre ne r gic 
agoni st that i ncr e a s e  th e p r oduct i o n  of cAMP. 
This cyclonuc l eotide then dir ect l y  ca u s e s  
a lterat ions i n  th e act iv ity of temp e rature-
s ens it ive neuron s that b r i n g  ab out an 
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(or  b o th ) . Ag = anti g en ;  Ag-Ab =an t i g en -
antibody c ompl exes ; Compl = c o mpl emen t; c AHP 
= c yc l i c 3 ' ,  5'-ad eno s i n e  mo nopho s ph a te;  
DHS  = d elay ed hyper s en s i tiv i t y ;  EP = endogenous 
pyrogen ;  SHT = s er o to n i n ;  LK = l ymphok i n e; 
N E  = no r e pi n eph r i n e; PO /AH pr eo ptic a r ea o f  
anter i o r  hypo th a l amus ; RE S = r e ti c u lo -
P a g e  
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end o the l i a l  s ys tem � i nh ib i t o rs ; " ac tiv a to r s. 
( F rom B ernh e i m  HA, B l o c k  L H , Atk i n s  E :  F ev er :  
Pa thog enes i s ,  patho phy s i o l o gy , a nd purpo s e. 
Ann In tern Med 9 1 :2 61 , 1 9 7 9 ) . 
A d o g  and goa t 1n res tra i n ing cages 43 
�lean f eb r i le res pon s e  o f  dogs  ( �If.) and 47 
goats (&----0) f o l l ow i n g  i n tra venous  i nj ec ti o n  
o f  LP S E .  c o l i  ( 0 .2 jJg/k g )  ( f i rs t  a r row) and 
a f ter the i n jec t i on o f  imi d o c arb d ipro pio n a te 
( s ec o n d  a rr ow )  i n  relation to time.  Each 
point r ep resen t s  th e mean o f  s i x  d o gs and 
s ix goats . 
Mean feb ri l e  r es pon s e  o f  d o g s  (�) and 48 
goa t s  (e---o) f o l l o wing in travenous  lno c u-
l 
l a ti on o f  10 spano s oma evan sJ:. and a f ter 
the
-
i nj ec ti o n  o f  imi d o c a rb d i pr o pi o na t e  ( ar ro w) 
i n  rel a tion to t ime.  E a c h  po i n t r epres en ts 
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Ne an f e b r i l e  re s po n s e  of goats f o l l owin g  
i n trav e n o u s  i n o c u l a ti o n  o f  I nf e c t i o u s  
B o v i n e  Rh i n o tra c he i tis ( IB R )  V i ru s  ( f i r s t  
a r row)  and a f te r  the i n je c t i o n  o f  i m i d o c a rb 
d i pr opi o n a te ( s e cond a r r o w) i n  r e l ati o n to 
time . Eac h  po i n t  r e pr e s ents the mean o f  
s ix goats .  
Standard c u rv e  o f  i m i d o c a rb in pl a sma o f  
goa t .  
Stan dard  c u rve o f  i m i d o c a rb in u r in e  o f  
goat. 
Im i d o ca r b  s tandard curve in b i l e 
Imi d o c a rb s tandard c u rv e  in ki dne y 
Imi do carb s tandard c u rv e  in l iv e r  
Imi do c a r b  s tandard c u rve in h e a r t  
Im i do c a rb s tand ard c u rv e  in mu s c l e  
Imi d o c a rb s tandard c u rve in f a t  
The l e a s t  s q u a r e s  non- l i ne a r  r e g re s s ion l i n e  
whi c h  b e s t  d e s c r ib e s  t h e  pl a sma c o n c entr a ti on -
time pro fi le in normal  d o g s . Da ta u sed f o r  
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construction of graph represents the mean ± SD 
concentration-time data 1n dogs (n=7). 
The least squares non-linear regress10n line 
Hhich best describes the plasma concentration­
time profile 1n normal goats. Data used for 
construction of graph represents the mean 
± SD concentration-time data in goats (n=8). 
Computer generated curves, based on m1cro­
constants associated with the t�o-compartment 
open model showing the level of imidocarb 1n 
compartments of the two-compartment open 
model. The fraction of dose in each of the 
compartments at 8-hours after a single 
intravenous injection (4 mg/kg) in dog is: 
6. 3% (central), 14.1% (peripheral), and 79. 6% 
(eliminated). The concentrations in plasma 
are ShOl,TO. 
Computer generated curves, based on m1cro­
constants associated with the two-compartment 
open model showing the level of imidocarb 
in compartments of the two-compartments open 
model. The fraction of dose in each of the 
compartments at 8-hours after a single 
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intravenous injection (4 mg/kg) 1n goats 1S: 
2.8% (central), 18.9% (peripheral), and 78.3% 
(eliminated). The concentrations in plasma are 
shown. 
Cumulative ur1nary excretion (mean + SD) of 
unchanged imidocarb in the normal dogs (n=7) 
and goats (n=8) following intravenous injection 
of a single dose (4 mg/kg) of 12% imidocarb 
dipropionate solution. 
Semilogarithmi� plot of the plasma concentra­
tion-time profiles for imidocarb which 
followed injection of the drug (4 rng/kg) 1n 
dogs by the intravenous and subcutaneous 
(n=7) routes. The symbols represent the 
concentration of imidocarb in the plasma after 
the administration of a single intravenous 
dose (---.) and a single subcutaneous dose 
Semilogarithmic plot of the plasma concentra­
tion-time profiles for imidocarb which followed 
injection of the drug (4mg/kg) 1n goats by 
the intravenous (n=8), subcutaneous (n=4) and 
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represent the concent rat i on of imid oca rb 1n 
the pla sma aft e r  the administ ration of a 
si n g l e  intravenous dose (�), s ubcutaneous d o s e  
(�) a n d  i ntramuscu l ar dose (=-�J). 
Co ncentration of imid ocarb (�g/ml) 1n p l asma 
of norma l d ogs (n=7) a nd goats (n=4) following 
s ubcutan e ous inject i on of a s in g l e  d os e  
(4 mg/kg) o f  12% i m i d oca rb d ipro p ionat e 
solut ion. 
C o nc e nt rat i o n  of i m i d ocarb (�g/ml) 1n p l asma 
of no rma l goats fol l o w ing subcut a n e ous (n=4) 
and i nt ramuscu l ar (n=4) i njection of a 
s in g l e  d ose (4 mg/kg) of 12% i m i d ocarb 
d iprop ionace so lut ion. 
Concentrat i o n  of imidocarb i n  va r i o us tissues 
of normal go ats fo l l Olving subcuta neous arrd 
intr amu scu lar i nject i on of a sing le dose 
(4 mg/kg) of 12% imidocarh d iprop i on ate 
sol ut i on. 
Cumu l at ive urlnary exc retion (mean + SD) of 
unchanged imidocarb in normal goats follo w in g  
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i njec t io n  o f  a s i n gle d o s e  (4 mg/k g )  o f  
12 % i m i d o c a rb d i pr o pi o n at e  s olu t i on .  
C umula t ive  u r 1nar y  exc r e t i on (mean + SD) of 
u nchanged im i d oca rb in n ormal g oa t s  fo ll ow i n g  
i n t raveno u s  ( n=8) a n d  s u b cu ta ne ou s  ( n= 4) 
i n j e cti o n  of a s i ng l e  dos e (4 mg/k g )  of 12% 
imi d o c a rb d i pr opi onate s oluti o n .  
C umula ti v e  Ur1l1ary e xc r e ti o n  (mean  + SD) of 
u nch a nged imi d oc a r b  1n n o rma l d og s  (n =7 ) 
f ol low i ng i n t raven ous a nd s u b c u ta ne ou s  
i n j e c t i o n  o f  a s i ng le d o s e  (4 mg/k g )  of 1 2 % 
i m i d o ca r b  d i pr opi ona t e  s o lu t ion. 
The l ea s t  s q u a re s  n on-li n e a r  r e g r e s s i on l i ne 
wh i ch b e st d e sc r ib e s  t h e  pl a sma c o nc e n t ra tion-
t i me pro fi le i n  end otoxi n-i nd uc e d  fe br i le 
dogs. Data used for construction of graph 
r e pr e s e nts t h e  mean ± SD c on c e n t r a t ion-ti me 
d a t a  i n  f eb r i l e  dog s ( n=6) .  
T h e  le ast squar e s  n o n-li n ea r  r e g r e s s lon line 
whi c h  bes t describes the plas ma co ncentr a t ion ­
t ime pro fi l e  i n  e n d otox i n -i n du c e d  feb rile 
goats . Dat a u s e d  f or c on s tru c t i on o f  graph 
re pre s e n t s  the mean ± SD c o nc e ntra ti o n-t i me 
d a ta i n  f e b r i le go a t s  (n =6). 
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T he le as t s q u a r e s  non-l i n e a r  r e g r e ssl0n l i ne s 
which b e s t  de sc r ibe s the p la sma concen t r a t i o n ­
time p ro f i l e  i n  norma l and e nd o tox i n -i n du ce d  
f e b r i l e  d o g s. Da ta u sed for  cons tru cti on o f  
g ra p hs r e p r e s e nts the mean ± SD con ce n tr a ti on­
ti me d a ta in n ' or mal ( n =7) and  f e b ril e d o g s  
( n= 6 )  . 
The lea s t  s q u a re s  non-l i ne a r  re g r e sslo n  l i ne s 
wh i ch b e s t  d e s cr i b e  the p l a sma con c e n tr a ti o n­
time p ro f ile s in n o rma l and e n do to xin - i n d u ce d  
f eb r i l e  goats . D a t a  u s e d  f o r  con s tr u c ti o n  o f  
graphs r e p r e s ents the mean ± SD con ce n tra ti on ­
ti me d a ta i n  norm a l  ( n = 8 )  and f eb r il e  goa ts 
( n =6 ) .  
C umu la ti v e  u r ln a r y  ex c r e ti o n  (me a n  + SD)  o f  
u n ch anged  i m i d o ca r b i n  the no rm a l  ( n =7 )  and 
feb r i l e  ( endotoxin -indu ced fev e r )  do gs ( n= 6 ) 
f ollowin g intravenous injection of a s i ngle 
d o s e  ( 4  mg /kg) o f  12% imi doc a rb d i p r o pi o n a te 
s o l ution . 
Cumu la tive urlnary excr e ti on (me a n  + SD ) o f  
u n c h a nged  i mid oca rb i n  the n o rma l (n= 8 )  a nd 
f e b r i l e  ( Endo to x i n - i ndu c ed f e ve r )  goa ts ( n =6 )  
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